NASDAQ:VIR | Free Cash Flow | Vir Biotechnology, Inc.

Free cash flow is operating cash flow less capital expenditure. FCF / net income requires positive matching-period earnings.

Available history
2017-12-31 to 2026-03-31
Data captured

Historical Free Cash Flow

DateOperating cash flowCapital expenditureFree cash flowFCF / net income
2026-03-31-$132.39M$390,000.00-$132.78M
2025-12-31-$25.88M$348,000.00-$26.22M
2025-03-31-$78.12M$1.63M-$79.75M
2024-12-31-$87.64M$2M-$89.63M
2024-03-31-$109.39M$1.87M-$111.26M
2023-12-31-$107.93M$1.54M-$109.46M
2023-03-31-$125.78M$6.87M-$132.65M
2022-12-31$35.13M$12.57M$22.55M
2022-03-31$550.09M$15.84M$534.25M103.01%
2021-12-31$7.7M$13.07M-$5.37M-1.02%
2021-03-31-$89.53M$667,000.00-$90.2M
2020-12-31-$82.05M$2.43M-$84.48M
2020-03-31-$48.41M$1.3M-$49.71M
2019-12-31-$38.89M$1.55M-$40.44M
2019-03-31-$29.49M$3.48M-$32.97M
2018-12-31-$29.51M$2.8M-$32.31M

Annual Free Cash Flow

DateOperating cash flowCapital expenditureFree cash flowFCF / net income
2025-12-31-$391.78M$4.83M-$396.61M
2024-12-31-$446.35M$7.3M-$453.65M
2023-12-31-$778.79M$21.57M-$800.36M
2022-12-31$1.66B$68.01M$1.6B309.25%
2021-12-31-$47.59M$21.82M-$69.41M-13.13%
2020-12-31-$190.94M$6.55M-$197.49M
2019-12-31-$129.63M$8.94M-$138.57M
2018-12-31-$94.1M$8.19M-$102.29M
2017-12-31-$66.38M$2.74M-$69.12M

Research interface only. Not investment advice. Prices are a checked-in snapshot, not live quotes.